[1]
|
F. E. Polmeteer and J. W. Kernohan, “Meningeal Glio-matosis: A Study of 42 Cases,” Archives of Neurology and Psychiatry, Vol. 57, No. 5, 1947, pp. 593-616.
|
[2]
|
H. Ikota, S. Kinjo, H. Yokoo and Y. Nakazato, “System-atic Immunohistochemical Profiling of 378 Brain Tumors with 37 Antibodies Using Tissue Microarray Technol-ogy,” Acta Neuropathologica, Vol. 111, No. 5, 2006, pp. 475-482. doi:10.1007/s00401-006-0060-1
|
[3]
|
E. Bongcam-Rudloff, M. Nistér, C. Betsholtz, J. L. Wang, G. Stenman, K. Huebner, C. M. Croce and B. Westermark, “Human Glial Fibrillary Acidic Protein: Complementary DNA Cloning, Chromosome Localization, and Messenger RNA Expression in Human Glioma Cell Lines of Various Phenotypes,” Cancer Research, Vol. 51, No. 5, 1991, pp. 1553-1560.
|
[4]
|
I. S. Cooper and J. W. Kernohan, “Heterotopic Nests in the Subarachnoid Space: Histologic Characteristics, Mode of Origin and Relation to Meningeal Gliomas,” Journal of Neuropathology and Experimental Neurology, Vol. 10, No. 1, 1951, pp. 16-21.
doi:10.1097/00005072-195110010-00002
|
[5]
|
M. Riva, S. Bacigaluppi, C. Galli, A. Citterio and M. Collice, “Primary Leptomeningeal Gliomatosis: Case Report and Review of the Literature,” Neurological Sci-ences, Vol. 26, No. 2, 2005, pp. 129-134.
doi:10.1007/s10072-005-0446-1
|
[6]
|
J. T. Rutka, J. R. Giblin, G. Apodaca, S. J. DeArmond, R. Stern and M. L. Rosenblum, “Inhibition of Growth and Induction of Differentiation in a Malignant Human Glioma Cell Line by Normal Leptomeningeal Extracel-lular Matrix Proteins,” Cancer Research, Vol. 47, No. 13, 1987, pp. 3515-3522.
|
[7]
|
G. A. Davis, G. C. Fabinyi, R. M. Kalnins, G. A. Brazenor and M. A. Rogers, “Concurrent Adjacent Meningioma and Astrocytoma: A Report of Three Cases and Review of the Literature,” Neurosurgery, Vol. 36, No. 3, 1995, pp. 599-604. doi:10.1227/00006123-199503000-00023
|